5 active trials 2 recruiting 2 disease areas 3 changes in 30 days
| Phase 2 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05872685 | Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced… | Adenocarcinoma of the Stomach | Recruiting | 2024-01-17 |
| NCT05729646 | Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or… | Adenocarcinoma of the Stomach | Recruiting | 2023-07-25 |
| NCT05715931 | Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally… | Adenocarcinoma of the Stomach | Active, Not Recruiting | 2026-09-09 |
| NCT04515615 | Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer… | Gastric Cancer Stage III | Active, Not Recruiting | 2024-09-19 |
| NCT05970627 | Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally… | Adenocarcinoma of the Stomach | Not Yet Recruiting | 2023-08-01 |
Gastric Cancer (5) · HER2-Positive Cancer (1)